{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020129",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020129_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"telotristat ethyl\" outputclass=\"int-heading-drug\">Telotristat ethyl</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"doravirine\" outputclass=\"int-drug\">doravirine</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid or adjust <xref format=\"dita\" href=\"drug/doravirine.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP219163\">doravirine</xref> or <xref format=\"dita\" href=\"drug/lamivudine-with-tenofovir-disoproxil-and-doravirine.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP219192\">lamivudine with tenofovir disoproxil and doravirine</xref> dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Telotristat ethyl   is predicted to   decrease   the exposure to   doravirine .  Manufacturer advises avoid or adjust  doravirine  or  lamivudine with tenofovir disoproxil and doravirine  dose .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Doravirine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020130",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020130_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"telotristat ethyl\" outputclass=\"int-heading-drug\">Telotristat ethyl</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"midazolam\" outputclass=\"int-drug\">midazolam</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Telotristat ethyl   decreases   the exposure to   midazolam .  Manufacturer advises monitor .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Midazolam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020131",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2#bnf_i1643858020131_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"octreotide\" outputclass=\"int-drug\">Octreotide</ph> <ph outputclass=\"int-substanceQualifier\">(short-acting)</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the exposure to</ph> <ph otherprops=\"telotristat ethyl\" outputclass=\"int-heading-drug\">telotristat ethyl</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"telotristat ethyl\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/telotristat-ethyl.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP216388\">telotristat ethyl</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"octreotide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/octreotide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP5807\">octreotide</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Octreotide   (short-acting)   decreases   the exposure to   telotristat ethyl .  Manufacturer advises  telotristat ethyl  should be taken at least 30 minutes before  octreotide .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Octreotide</title>"
					}
				}
			],
			"hasSearchLabel": " Telotristat ethyl  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/telotristat-ethyl-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Telotristat ethyl </title>"
			},
			"rdfs:label": "telotristat ethyl"
		}
	]
}